CCC Intelligent Solutions (CCC) News Today: Advent Prices 37.3M‑Share Secondary at $7.79; Ticker Now “CCC”

7 November 2025

Advent International priced a 37,342,526‑share secondary offering at $7.79; the sale represents all shares held by Advent affiliates and CCC receives no proceeds. Closing was expected today (Nov. 7), subject to customary conditions. Goldman Sachs is book‑runner. ^[1]
The sale equals ~5.8% of shares outstanding, signaling a full exit by the selling stockholder group. Pre‑market reaction yesterday was modestly lower. ^[2]
Reminder: the company changed its Nasdaq ticker to “CCC” effective Oct. 31, 2025 (many outlets still reference “CCCS”). ^[3]

What happened

CCC Intelligent Solutions said affiliates of Advent International (the selling stockholders) priced a secondary offering of 37,342,526 common shares at $7.79. The company itself is not issuing shares and will not receive proceeds. The release noted the offering was expected to close on or about Friday, Nov. 7, 2025, pending customary conditions; Goldman Sachs & Co. LLC is acting as book‑running manager. ^[4]

A related prospectus supplement details the $7.79 offer price and expected Nov. 7 settlement, aligning with the company’s announcement. ^[5]

Market reports framed the sale as Advent’s full exit (~5.8% stake); shares traded slightly lower on the news. ^[6]

Context you should know

Ticker change: CCC replaces CCCS

CCC confirmed in October that its Nasdaq ticker switched to “CCC” on Oct. 31, 2025. If you see “CCCS” in third‑party articles or data feeds, it’s likely legacy labeling. ^[7]

Earnings backdrop (reported Oct. 30)

Q3 2025 revenue:$267.1M, up 12% year over year.
GAAP gross margin:72%; Adjusted EBITDA:$110.1M (+8% Y/Y).
GAAP net:($2.0M); Adjusted net income:$59.4M.
Guidance:Q4 revenue $272–$277M; FY25 revenue $1.051–$1.056B; FY25 adjusted EBITDA $423–$428M. ^[8]

Today on the tape: fund flows item

A MarketBeat note published today says Summit Creek Advisors trimmed its position based on historical filings; as is typical with holdings stories, the underlying transactions occurred in prior periods even though the write‑up is dated Nov. 7. ^[9]

What it could mean for investors

Technical float dynamics: Because CCC doesn’t issue new shares and gets no cash, the event is chiefly about ownership rotation from a PE holder to the public market. Such blocks can pressure shares near the $7.79 print in the short term, but they also remove overhang from a large legacy holder post‑deal. ^[10]
Signal value: A complete exit by the selling stockholders cleans up the cap table and may improve liquidity; however, near‑term supply can keep trading anchored around the deal price until absorption. (This is a market‑structure observation, not a forecast.)
Fundamentals remain the anchor: Q3 showed double‑digit revenue growth and 40%+ adjusted EBITDA margin, while FY guidance implies steady execution into year‑end. Keep an eye on whether Q4 revenue ($272–$277M) lands inside the guided range. ^[11]

Key facts & dates

Deal size:37,342,526 shares at $7.79. Book‑runner:Goldman Sachs & Co. LLC. Issuer proceeds:$0 (all secondary). Expected closing/settlement:Nov. 7, 2025. ^[12]
Stake context: ~5.8% of outstanding shares (based on ~640–642M shares outstanding), indicating a full exit of the selling stockholders’ remaining position. ^[13]
Ticker:CCC (effective Oct. 31, 2025; previously CCCS). ^[14]

Recent timeline

Nov. 7, 2025: Story still developing as the offering was expected to close today. ^[15]
Nov. 6, 2025: Company published pricing release; market commentary noted mild pre‑market weakness. ^[16]
Oct. 30, 2025:Q3 2025 results and FY outlook issued. ^[17]
Oct. 31, 2025:Ticker change to “CCC” took effect. ^[18]

Sources & references

Company news release (pricing of secondary offering): Nov. 6, 2025. ^[19]
Prospectus supplement details (424B3 summary): pricing/settlement information. ^[20]
Market color (Reuters/TradingView feed): Advent exit and pre‑market move. ^[21]
Q3 2025 earnings press release: revenue, profitability, guidance. ^[22]
Holdings note (published today): Summit Creek Advisors position change (historical filing). ^[23]

Editorial note: This article is for informational purposes only and does not constitute investment advice. Always do your own research and consider consulting a licensed financial professional.

Best Programming Languages #programming #coding #javascript

Watch this video on YouTube.

References

Tags:

Mateusz Kaczmarek Latest posts

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

View all

Canaccord Genuity Lowers Enovix Target to $21; Analysts Split on ENVX Outlook
November 7, 2025, 9:10 PM EST. Analysts are split on Enovix (ENVX) after Canaccord Genuity Group trimmed its price target from $22 to $21, maintaining a Buy rating as the stock hovers around $9.02. The new target implies roughly 133% upside from the close, per MarketBeat data. Other firms diverged: Wall Street Zen downgraded to Sell; Cantor Fitzgerald cut to $25 with an Overweight; Weiss Ratings reiterated Sell; Benchmark raised to $25 with a Buy; JPMorgan kept Neutral and raised its target to $12. Overall, five analysts rate Buy, four Hold, one Sell, yielding a Hold consensus and a $17.89 average target. ENVX traded ~21.8M shares, with a 12-month high/low of $16.49 and $5.27. The company posted a quarterly loss and disclosed insider selling from COO Ajay Marathe.
Analysts Cut 2025 Revenue Outlook for Zai Lab (NASDAQ: ZLAB) as Downgrade Signals Caution
November 7, 2025, 9:06 PM EST. Analysts have just issued a major downgrade for Zai Lab (NASDAQ: ZLAB), cutting near-term revenue forecasts and signaling a more cautious outlook. The latest consensus now calls for about US$485m in 2025 revenue, down from prior estimates of around US$556m. While the growth pace remains positive, the downgrade marks a notable pullback from the last year's performance and mirrors a broader deceleration: projected annualized revenue growth slows to about 20% through 2025, below the ~35% seen over the past five years and in line with the wider industry. The consensus price target sits at about US$53.40, offering limited upside given the softer outlook. Overall, the downgrade underscores increased caution on ZLAB and its near-term trajectory, even as some upside remains contingent on execution and pipeline progress.
What weighed on stocks this week? AI pressure, labor data, and a busy earnings season update
November 7, 2025, 9:02 PM EST. Markets faced a lackluster week as the S&P 500 slipped, with AI-related names under pressure as multiples contract and funding concerns loom. The week trimmed gains as investors weighed a mixed labor market picture: ADP payrolls beat expectations midweek, but rising layoff announcements signaled trouble ahead. The ongoing government shutdown weighed on travel and consumer activity, with sentiment near multi-decade lows. In response, the club added three new buys-Starbucks, Boeing, and GE Vernova-while keeping about 7% cash for opportunistic bets. In earnings, roughly 90% of the S&P 500 members reported, with about 77% beating on revenue and 82% on EPS, still above long-run averages but down from last week. Next week centers on Cisco, Disney, CoreWeave, On, and Applied Materials, noting data delays from the shutdown.
Palantir Stock Sinks Despite Strong Q3 Beat as AI Valuations Wobble
November 7, 2025, 8:56 PM EST. Palantir Technologies (PLTR) extended a week-long slide, down about 14% after its Q3 report, even though the results topped Wall Street estimates. The company posted non-GAAP EPS of $0.21 on revenue of $1.18 billion, beating expectations of $0.17 and $1.09 billion. Growth was led by a 52% rise in the U.S. government segment to $486 million and overall revenue up 63%. The selloff reflects growing skepticism about AI valuations amid macro jitters and a bearish bet from Michael Burry's Scion Asset Management, which reportedly took $912 million in put options on Palantir. The move underscores ongoing concerns that AI names are in a bubble, and Palantir could remain volatile as investors weigh fair value against big-growth narratives.
Howard Hughes Holdings intrinsic value: DCF places fair value near market price
November 7, 2025, 8:54 PM EST. Howard Hughes Holdings Inc. (NYSE: HHH) appears near its estimated fair value after a two-stage Discounted Cash Flow (DCF) analysis. The model yields a fair value of US$91.22 per share, vs. a US$78.25 market price, suggesting the stock trades close to fair value. The analysis uses a two-stage FCF to Equity approach, projecting ten years of cash flows and a conservative terminal value, with a PVCF of about US$3.2b. An industry peers' discount to fair value of 6.4% implies broader peers are trading at larger discounts. Note that multiple methods exist; the DCF is just one framework, and assumptions (growth, discount rate) materially affect outcomes. The summary references analyst estimates for growth rates in the initial period and then slowing growth toward a steady state.

CCC Intelligent Solutions (CCC) News Today: Advent Prices 37.3M‑Share Secondary at $7.79; Ticker Now “CCC” — Nov. 7, 2025

What happened